Skip to main content

CORRECTION article

Front. Immunol., 11 June 2024
Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Corrigendum: Candidate biomarkers for the prediction and monitoring of partial remission in pediatric type 1 diabetes

  • 1Immunology Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain
  • 2Department of Political and Social Sciences, Health Inequalities Research Group (GREDS-EMCONET), Pompeu Fabra University, Barcelona, Spain
  • 3Johns Hopkins University–Pompeu Fabra University Public Policy Center, Barcelona, Spain
  • 4Pediatrics Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain
  • 5Endocrinology Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain
  • 6Pediatric Endocrinology Department, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Autonomous University of Barcelona, Sabadell, Spain
  • 7Cruces University Hospital, Biocruces Bizkaia Research Institute, UPV/EHU, CIBERDEM, CIBERER, Endo-ERN, Bilbao, Spain

A Corrigendum on:
Candidate biomarkers for the prediction and monitoring of partial remission in pediatric type 1 diabetes

By Gomez-Muñoz L, Perna-Barrull D, Caroz-Armayones JM, Murillo M, Rodriguez-Fernandez S, Valls A, Vazquez F, Perez J, Corripio R, Castaño L, Bel J and Vives-Pi M (2022) Front. Immunol. 13:825426. doi: 10.3389/fimmu.2022.825426

In the published article, there was an error in the Funding statement. One of the funding bodies was incorrectly listed as “the Spanish Government (FIS PI18/00436)”. The correct Funding statement appears below.

Funding

“This study has been funded by Instituto de Salud Carlos III through the project PI18/00436 (Co-funded by European Regional Development Fund ‘A way to make Europe’), and by DiabetesCero Foundation. LGM is supported by the Generalitat de Catalunya (PERIS PIF-Salut Grant No. SLT017/20/000049). This work has been supported by positive discussion through Consolidated Research Group #2017 SGR 103, AGAUR, Generalitat de Catalunya.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: type 1 diabetes (T1D), partial remission phase, honeymoon, biomarkers, pediatrics, prediction model, immune cell subpopulations, autoimmunity

Citation: Gomez-Muñoz L, Perna-Barrull D, Caroz-Armayones JM, Murillo M, Rodriguez-Fernandez S, Valls A, Vazquez F, Perez J, Corripio R, Castaño L, Bel J and Vives-Pi M (2024) Corrigendum: Candidate biomarkers for the prediction and monitoring of partial remission in pediatric type 1 diabetes. Front. Immunol. 15:1439643. doi: 10.3389/fimmu.2024.1439643

Received: 28 May 2024; Accepted: 04 June 2024;
Published: 11 June 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Gomez-Muñoz, Perna-Barrull, Caroz-Armayones, Murillo, Rodriguez-Fernandez, Valls, Vazquez, Perez, Corripio, Castaño, Bel and Vives-Pi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Marta Vives-Pi, bXZpdmVzQGlndHAuY2F0

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.